Company Overview and News

0
Marathon Nextgen Realty Limited - Reply to Clarification- Financial results

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Clarification - Financial Results

2018-05-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Dividend

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Financial Result Updates

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Outcome of Board Meeting

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Trading Window

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

0
Marathon Nextgen Realty gains 7% on fixing record date for stock split

2018-03-26 moneycontrol
Share price of Marathon Nextgen Realty gained 7 percent intraday Monday on fixing record date for stock split.
MARATHON 503101

0
Marathon Nextgen Realty Limited - Record Date

2018-03-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

86
Market Live: Nifty struggles below 10,000, midcaps in the red; GAIL, HPCL, BPCL, IOC dip

2018-03-26 moneycontrol
11:03 am Stake Sale: Power Mech Projects said the company has identified buyer for disinvestment of its entire shareholding in Power Mech - CPNED Services (Hong Kong) Holding Co. Ltd., joint venture (50 percent) of the company.
BGX AUTOIND BHUSANSTL BGLF 532832 532797 CADILAHC 532321 532482 500570 CLNDY 500055 AXB 524804 TATAPOWER YYBKY BX 539302 JSWSTEEL BGB GUJGAS AXBA TATASTEEL TATLY KOTAKBANK COALINDIA IBREALEST WABAG MARATHON AUROPHARMA 500228 539336 TATACOMM 533278 532215 GRANULES 500470 AXISBANK 503101 TATAMOTORS YESBANK KMBKY IBN 532648 VTUWY CDLYY 533269 AXBKY POWERMECH ICICIBANK TTST 532174 ARBQY TPCL 500400 500247 500483 TTM

44
Market Live: Nifty rangebound despite global weakness; GAIL, HPCL, BPCL, IOC dip

2018-03-26 moneycontrol
10:02 am Rupee Trade: The rupee strengthened by 10 paise to 64.91 against the US dollar at the interbank forex market on sustained selling of the greenback by exporters and banks amid foreign capital inflows.
AUTOIND BHUSANSTL 532832 532797 CADILAHC 532321 532482 500570 CLNDY 500055 AXB 524804 TATAPOWER YYBKY JSWSTEEL GUJGAS AXBA TATASTEEL TATLY KOTAKBANK COALINDIA IBREALEST WABAG MARATHON AUROPHARMA 500228 539336 533278 532215 GRANULES 500470 AXISBANK 503101 TATAMOTORS YESBANK KMBKY IBN 532648 VTUWY CDLYY 533269 AXBKY ICICIBANK TTST 532174 ARBQY TPCL 500400 500247 TTM

0
Marathon Nextgen Realty Limited - Shareholders meeting

2018-03-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MARATHON 503101

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NSE:MARATHON / MARATHON NEXTGEN REALTY LTD. on message board site Silicon Investor.

Marathon Oil Oil Svcs : USX- Marathon [MRO]